DCM
DAFNA Capital Management Portfolio holdings
AUM
$362M
This Quarter Return
+13.9%
1 Year Return
-0.48%
3 Year Return
+117.01%
5 Year Return
+181.93%
10 Year Return
+1,483.26%
AUM
$366M
AUM Growth
+$366M
(+9.7%)
Cap. Flow
-$2.7M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
49.41%
Holding
80
New
7
Increased
18
Reduced
15
Closed
7
Top Buys
| 1 |
Day One Biopharmaceuticals
DAWN
|
$6.05M |
| 2 |
TSVT
2seventy bio
TSVT
|
$5.02M |
| 3 |
Tandem Diabetes Care
TNDM
|
$2.7M |
| 4 |
Merus
MRUS
|
$2.66M |
| 5 |
Kura Oncology
KURA
|
$2.62M |
Top Sells
| 1 |
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
|
$7.89M |
| 2 |
CSII
Cardiovascular Systems, Inc.
CSII
|
$5.7M |
| 3 |
Biohaven
BHVN
|
$5.13M |
| 4 |
Apellis Pharmaceuticals
APLS
|
$3.81M |
| 5 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$2.79M |
Sector Composition
| 1 | Healthcare | 82.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Arcus Biosciences
RCUS
$1.24B
| $4.58M | 1.25% |
225,717
+50,500
| +29% | +$1.03M |
|
27
Century Therapeutics
IPSC
$40.4M
| $4.13M | 1.13% |
1,307,407
| – | – |
|
28
Edgewise Therapeutics
EWTX
$1.54B
| $4.03M | 1.1% |
519,384
-213,855
| -29% | -$1.66M |
|
29
BioCryst Pharmaceuticals
BCRX
$1.74B
| $4.01M | 1.1% |
569,000
+17,500
| +3% | +$123K |
|
30
Alector
ALEC
$282M
| $3.84M | 1.05% |
638,938
+46,500
| +8% | +$279K |
|
|
31
Kura Oncology
KURA
$732M
| $3.79M | 1.04% |
357,784
+248,000
| +226% | +$2.62M |
|
|
MRTX
32
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $3.42M | 0.94% |
94,700
+21,100
| +29% | +$762K |
|
|
BCYC
33
Bicycle Therapeutics
BCYC
$492M
| $3.12M | 0.85% |
122,200
| – | – |
|
34
Axogen
AXGN
$723M
| $3.03M | 0.83% |
332,103
| – | – |
|
35
MediWound
MDWD
$180M
| $2.75M | 0.75% |
257,653
| – | – |
|
|
36
Tandem Diabetes Care
TNDM
$834M
| $2.7M | 0.74% |
+110,000
| New | +$2.7M |
|
37
Mersana Therapeutics
MRSN
$34.8M
| $2.67M | 0.73% |
32,434
+11,999
| +59% | +$987K |
|
|
AUTL
38
Autolus Therapeutics
AUTL
$383M
| $2.21M | 0.61% |
930,394
-245,756
| -21% | -$585K |
|
39
Galapagos
GLPG
$2.06B
| $2.14M | 0.59% |
52,675
| – | – |
|
40
Adicet Bio
ACET
$60.8M
| $1.94M | 0.53% |
797,054
| – | – |
|
41
Keros Therapeutics
KROS
$638M
| $1.92M | 0.52% |
47,661
+28,300
| +146% | +$1.14M |
|
|
RGLS
42
DELISTED
Regulus Therapeutics
RGLS
| $1.63M | 0.45% |
1,111,049
+555,494
| +100% | +$817K |
|
|
VIGL
43
DELISTED
Vigil Neuroscience
VIGL
| $1.62M | 0.44% |
172,308
| – | – |
|
44
ProQR Therapeutics
PRQR
$256M
| $1.52M | 0.42% |
940,582
| – | – |
|
45
Lyra Therapeutics
LYRA
$11.8M
| $1.48M | 0.41% |
+7,222
| New | +$1.48M |
|
|
MREO
46
Mereo BioPharma
MREO
$275M
| $1.33M | 0.36% |
1,009,013
-87,500
| -8% | -$116K |
|
|
ITOS
47
DELISTED
iTeos Therapeutics
ITOS
| $1.3M | 0.36% |
98,560
| – | – |
|
|
BWAY
48
Brainsway
BWAY
$296M
| $1.15M | 0.31% |
504,681
+30,700
| +6% | +$70K |
|
49
Sutro Biopharma
STRO
$85.6M
| $1.13M | 0.31% |
242,779
+158,079
| +187% | +$735K |
|
50
Larimar Therapeutics
LRMR
$337M
| $1.1M | 0.3% |
350,373
+113,500
| +48% | +$355K |
|